Dr. Laws, former immunology leader at Sanofi, will oversee global development of Kymera’s KT-621 program. KT-621 parallel Phase 2b trials advancing in AD and asthma, with data e ...

Company completes approximately 3,500 meters of drilling, begins receiving assay results from its infill-focused program, continues advancing the PEA and strengthens development capabilities with the ...

On July 2, 2026, the Canadian federal government, along with the provincial governments in Alberta and British Columbia, ...

Toronto Maple Leafs prospect Tinus Luc Koblar is taking in his second development camp fresh off of an impressive performance ...

While there has been some adaptive reuse of buildings staff note that overall “development over the past 14 years has not ...

The World Bank will stop lending to China after $69 billion across 452 projects. Here's why this long-expected graduation ...

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How is the field adapting to meet these new demands?

New research reveals developers are rapidly adopting AI agents, creating new challenges around coordination, control, ...

Neuland Laboratories said it will invest $20 million to open a dedicated process-development laboratory and integrated kilo lab at its Genome Valley campus, a move aimed at strengthening the company’s ...

Abstract: Sign languages are used by the deaf and mute community of the world. These are gesture based languages where the subjects use hands and facial expressions to perform different gestures.

Learn what Claude Code is, how Anthropic’s AI coding agent works, where it excels, its limits, pricing concerns, and who ...

A study has used eye-tracking techniques to analyze the processes of selective attention that determine the way in which we explore and interact with our environment. Researchers studied the movements ...